Modular Medical Announces Licensing Agreement with Nudge BG
19 Dec 2024 //
ACCESSWIRE
Modular Medical Schedules Call for Business Update
03 Dec 2024 //
ACCESSWIRE
Modular Medical Announces Proposed Public Offering
21 Nov 2024 //
ACCESSWIRE
Modular Medical Announces Pricing of $8.2 Million Public Offering
21 Nov 2024 //
ACCESSWIRE
Modular Medical Sponsors ADEPT Diabetes Conference
11 Nov 2024 //
ACCESSWIRE
Tribe Public Webinar on GLP-1 Weight Loss Treatments Nov. 11
08 Nov 2024 //
ACCESSWIRE
Modular Medical Announces Successful GLP-1 Proof of Concept Study
07 Nov 2024 //
ACCESSWIRE
Modular Medical To Present At Lytham Partners Fall 24 Conference
30 Sep 2024 //
ACCESSWIRE
Modular Medical Announces Issuance Of U.S. Patent
18 Sep 2024 //
ACCESSWIRE
Modular Medical Finalizes GLP-1 Study Protocol Using MODD1 Platform
11 Sep 2024 //
ACCESSWIRE
Tribe Public Webinar On Modular Medical`s Diabetes Care Innovation
08 Aug 2024 //
ACCESSWIRE
Modular Medical Transfers Manufacturing To Phillips Medisize
07 Aug 2024 //
ACCESSWIRE
Modular Medical Announces MODD1 Platform Study For Metabolic Therapy
15 Jul 2024 //
ACCESSWIRE
Modular Medical Announces Addition to the Russell Microcap(R) Index
03 Jun 2024 //
ACCESSWIRE
Modular Medical To Present At Lytham Spring Conference
21 May 2024 //
ACCESSWIRE
Modular Medical Announces Steve Gemmell as New Vice President of Engineering
26 Mar 2024 //
ACCESSWIRE
Modular Medical Announces Closing of $10 Million Public Offering
21 Feb 2024 //
ACCESSWIRE
Modular Medical Announces Proposed Public Offering
15 Feb 2024 //
ACCESSWIRE
Modular Medical Announces Issuance of New US Patent
24 Jan 2024 //
ACCESSWIRE